Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma

NCT06183983 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06183983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06183983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hitting the Mark: Introducing State-of-the-art MRI for Precision Radiotherapy of Glioblastoma
Lead sponsor
Erasmus Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
January 3, 2024
Completion date
August 31, 2026
Enrollment
53 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma